- Capital Cube•10 hours ago
Click here to see latest analysisElite Pharmaceuticals, Inc. reports financial results for the year ended March 31, 2016.HighlightsGross margins widened from 27.61% to 58.80% compared to the same period last year, operating (EBITDA) margins now -61.22% from -316.83%.Change in operating cash flow of 81.69% compared to same period last year is about the same as […] (Read more...) The post Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
- Insider Monkey•8 days ago
Two biotech companies had a rough end to the week last week, and it looks as though things aren’t going to get much better for them heading into the US open on Monday. Here’s what happened. Elite Pharmaceuticals Inc (OTCMKTS:ELTP) Of the two companies we’re looking at, Elite had the tougher time. On Friday, the […]
|52wk Range||0.15 - 0.44|
|Day's Range||0.15 - 0.18|
|Avg Vol (3m)||1,779,452|
As of 3:58 PM EDT. Market closed.